Xenon Pharmaceuticals (XENE) EBITDA Margin (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Xenon Pharmaceuticals | 4.78 Bn | 4.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.38 Mn |
| Jun 30, 2022 | -561,492.00 |
| Mar 31, 2022 | -107,732.00 |
| Dec 31, 2021 | 122,580.00 |
| Sep 30, 2021 | 66,772.00 |
| Jun 30, 2021 | -64,584.00 |
| Mar 31, 2021 | -57,281.00 |
| Dec 31, 2020 | 35,230.00 |
| Sep 30, 2020 | -14,316.00 |
| Jun 30, 2020 | 10,867.00 |
| Mar 31, 2020 | -71,379.00 |
| Dec 31, 2019 | 85,604.00 |
| Dec 31, 2017 | -4.70 Mn |
| Sep 30, 2017 | 4.93 Mn |
| Jun 30, 2017 | -270,125.00 |
| Mar 31, 2017 | -4.85 Mn |
| Dec 31, 2016 | 32,240.00 |
| Sep 30, 2016 | -23,366.00 |
| Jun 30, 2016 | -59,997.00 |
| Mar 31, 2016 | -81,943.00 |
| Dec 31, 2015 | -3,288.00 |
| Sep 30, 2015 | -11,799.00 |
| Jun 30, 2015 | 25,720.00 |
| Mar 31, 2015 | -21,244.00 |
| Dec 31, 2014 | -7,409.00 |
| Sep 30, 2014 | 1,764.00 |
| Jun 30, 2014 | 3,128.00 |
| Mar 31, 2014 | -2,689.00 |
| Dec 31, 2013 | -2,426.00 |